Febrile neutropenia in children treated for malignancy
- 1 June 2015
- journal article
- review article
- Published by Elsevier in Journal of Infection
- Vol. 71, S27-S35
Abstract
No abstract availableKeywords
This publication has 53 references indexed in Scilit:
- Preventing CLABSIs Among Pediatric Hematology/Oncology Inpatients: National Collaborative ResultsPediatrics, 2014
- Impact of a central venous line care bundle on rates of central line associated blood stream infection (CLABSI) in hospitalised childrenJournal of Infection Prevention, 2014
- A reaudit of current febrile neutropenia practice in UK paediatric oncology centres prior to implementation of NICE guidanceArchives of Disease in Childhood, 2013
- The Diagnostic Value of Interleukin-6 and Interleukin-8 for Early Prediction of Bacteremia and Sepsis in Children With Febrile Neutropenia and CancerJournal of Pediatric Hematology/Oncology, 2012
- Cochrane Review: Anti‐pseudomonal beta‐lactams for the initial, empirical, treatment of febrile neutropenia: comparison of beta‐lactamsEvidence-Based Child Health: A Cochrane Review Journal, 2011
- A Hospital-wide Quality-Improvement Collaborative to Reduce Catheter-Associated Bloodstream InfectionsPediatrics, 2011
- CLABSI Rates in Immunocompromised Patients: A Valuable Patient Centered Outcome?Clinical Infectious Diseases, 2011
- Clinical Practice Guideline for the Use of Antimicrobial Agents in Neutropenic Patients with Cancer: 2010 Update by the Infectious Diseases Society of AmericaClinical Infectious Diseases, 2011
- A Prospective Study on the Epidemiology of Febrile Episodes during Chemotherapy-Induced Neutropenia in Children with Cancer or after Hemopoietic Stem Cell TransplantationClinical Infectious Diseases, 2007
- Evolving concepts of management of febrile neutropenia in children with cancerMedical and Pediatric Oncology, 2002